1 / 26

Age of Transfused Blood: Short-Term Mortality and Long-Term Survival after Cardiac Surgery

Age of Transfused Blood: Short-Term Mortality and Long-Term Survival after Cardiac Surgery. Thursday May 1, 2008 FDA Blood Products Advisory Committee 91 st Annual Meeting Rockville, MD. Mark Stafford-Smith, MD, CM, FRCPC, FASE Professor of Anesthesiology

paul
Download Presentation

Age of Transfused Blood: Short-Term Mortality and Long-Term Survival after Cardiac Surgery

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Age of Transfused Blood: Short-Term Mortality and Long-Term Survival after Cardiac Surgery Thursday May 1, 2008 FDA Blood Products Advisory Committee 91st Annual Meeting Rockville, MD Mark Stafford-Smith, MD, CM, FRCPC, FASE Professor of Anesthesiology Division of Cardiothoracic Anesthesia & Critical Care Medicine Duke Heart Center, Durham, NC

  2. Age of Transfused Blood: Short-term Mortality and Long-term Survival after Cardiac Surgery Disclosure: No financial relationships to disclose pertinent to the content of this CME presentation Consultant for Polymedix Inc.

  3. http://www.resource4thepeople.com/defectivedrugs/avandia.htmlhttp://www.resource4thepeople.com/defectivedrugs/avandia.html

  4. Problems for Established Therapeutic Interventions Efficacy vs. Safety 2002 - estrogen/medroxyprogesterone acetate vs. myocardial infarction 2004 - SSRI antidepressants, teen suicide link 2005 - cyclooxygenase 2 inhibitor (Vioxx) vs. myocardial infarction 2007 - rosiglitazone (Avandia) vs. myocardial infarction 2008 - aprotinin (Trasylol) vs. postop kidney dysfunction and mortality http://www.fda.gov/cder/drug/infopage/cox2/NSAIDdecisionMemo.pdf http://washingtontimes.com/national/20040208-123823-1958r.htm McEvoy et al. Anesth Analg 2007; 105:949-962 http://www.fda.gov/cder/drug/safety/WHI_statement.htm

  5. Ho et al. Crit Care Med 2003;31:S687-97 2003 - UK – SHOT analysis, TRALI and plasma donor gender

  6. Liberal versus Restrictive Transfusion N=838 critically ill patients Hb<9.0g/dL Randomized to one of two groups within 72h of ICU admission Transfusion Strategy Restrictive – trigger <7.0g/dL, target 7-9 Liberal – trigger <10g/dL, target 10-12 Hébert et al. New Engl J Med 1999;340:409-17

  7. Odds ratio for 30 day mortality for patients who received a blood transfusion as compared to those who did not. Myocardial Infarction and Transfusion n=78,974 elderly (>65y) with MI crude 30-day mortality correlated with decreasing admission Hct 3,680 (4%) received a transfusion Wu W-C et al N Engl J Med 2001;345;1230-6

  8. Harm Associated with Transfusion Multiorgan failure - trauma patients, prospective cohort transfusion Arch Surg 1997;132:620-5 30 day mortality - critically ill patients, prospective RCT restrictive vs. liberal N Engl J Med 1999;340:409-17 28 day / ICU mortality - critically ill patients, prospective cohort and LOS transfusion JAMA 2002;288:1499-1507 ICU mortality and - postop cardiac surgery patients, prospective cohort mechanical ventilation transfusion Anesthesiology 2003;98:815-22 Mortality 24h/in-hosp - trauma patients, prospective and LOS ICU/Hosp transfusion J Trauma 2003;54:898-907 Mortality in-hosp, 30d. - meta-analysis (15 trials) 60d, 90d no association leukored vs. non Vox Sang 2002;82:141-149 (cardiac surgery subgroup (3RCTs) – leukoreduced reduced 22-66 months mortality) Ho et al. Crit Care Med 2003;31:S687-97

  9. Age Distribution of Transfused Blood 20% of packed red cells are transfused >28 days old 10-38% packed red cellstransfused within 2 days of expiry Ho et al. Crit Care Med 2003;31:S687-97 DeSimone et al. Anesth Analg 2005;100:SCA7 VanMatre et al. Anesth Analg 2007;104:SCA23 Vamvakas et al. Transfusion 2000;40:101-9

  10. Adverse Changes (“Storage Lesion”) in Stored Red Blood Cells Bennett-Guerrero et al PNAS 2007;43:17063-8

  11. Prolonged Storage and Outcomes after Red Cell Transfusion Length of ICU stay - 698 septic patients, retrospective blood >14days Clin Invest Med 1994;17:B21 Mortality - 31 septic patients, retrospective blood >16days Can J Anaesth 1997;44:1256-61 Multiorgan failure - trauma patients, prospective cohort #units >14days, >21days Am J Surg 1999;178:570-2 Major infections - cardiac surgery patients, retrospective age of oldest unit Anesthesiology 2003;98:815-22 Postop pneumonia - 416 CABG surgery patients, retrospective age of blood Transfusion 1999;39:701-10 Gastric pH - septic patients, prospective blood >16days JAMA 1993;269:3024-3029 Ho et al. Crit Care Med 2003;31:S687-97

  12. Interaction between Leukoreduction and Blood Storage Longer storage of blood + WBC’s → greater accumulation of WBC-derived cytokines Postop pneumonia - 416 CABG surgery patients, retrospective age of blood, non- vs. leukored Transfusion 1999;39:701-10 http://images.encarta.msn.com/xrefmedia/sharemed/targets/images/pho/35a5c/35A5C297.jpg

  13. 57 transfused ICU/cardiac surgery patients • Canadian Medical Centers • Standard group • Median age transfusion 19 days • Experimental group • - Median age transfusion 19 days Hebert et al. Anesth Analg 2005;100:1433-8

  14. Age of Stored Blood and Post-Cardiac Surgery Mortality Risk Koch et al. New Engl J Med 2008;358:1229-39

  15. Age of Stored Blood and Post-Cardiac Surgery Mortality Risk • single institution • transfused CABG, Valve or CABG/Valve surgery patients • June 30, 1998 - January 30, 2006 • 2,872 patients - blood stored <14 days (8,802 units) • 3,130 patients - blood stored >14 days (10,782 units) • Propensity-adjusted, multivariable logistic regression analysis • to examine the association of storage age on postoperative mortality • Kaplan-Meier and Brownstone Decompensation method to assess • association of storage age on long-term survival Koch et al. New Engl J Med 2008;358:1229-39

  16. Age of Stored Blood and Post-Cardiac Surgery Mortality Risk Koch et al. New Engl J Med 2008;358:1229-39

  17. Age of Stored Blood and Post-Cardiac Surgery Mortality Risk Koch et al. New Engl J Med 2008;358:1229-39

  18. Age of Stored Blood and Post-Cardiac Surgery Mortality Risk Koch et al. New Engl J Med 2008;358:1229-39

  19. Age of Stored Blood and Post-Cardiac Surgery Mortality Risk Koch et al. New Engl J Med 2008;358:1229-39

  20. Age of Stored Blood and Post-Cardiac Surgery Mortality Risk Koch et al. New Engl J Med 2008;358:1229-39

  21. Age of Stored Blood and Long-Term Survival Koch et al. New Engl J Med 2008;358:1229-39

  22. Age of Stored Blood and Post-Cardiac Surgery Mortality Risk • single institution • 4643 transfused CABG surgery patients • September 1993 - June 2002 DeSimone et al. Anesth Analg 2005;100:SCA7 VanMatre et al. Anesth Analg 2007;104:SCA23

  23. Age of Stored Blood and Post-Cardiac Surgery Mortality Risk • Propensity-adjusted, multivariable logistic regression analysis • to examine the association of storage age of the oldest transfusion on postoperative mortality • - Cubic-Splines analysis to assess for curvilinear relationships • Kaplan-Meier method to assess the association of storage age of the oldest transfusion on long-term survival DeSimone et al. Anesth Analg 2005;100:SCA7 VanMatre et al. Anesth Analg 2007;104:SCA23

  24. Age of Stored Blood and Post-Cardiac Surgery Mortality Risk DeSimone et al. Anesth Analg 2005;100:SCA7

  25. Age of Stored Blood and Post-Cardiac Surgery Mortality Risk VanMatre et al. Anesth Analg 2007;104:SCA23

  26. “…the COX-2 saga has served to demonstrate that an approach (to drug development) based on studies powered to show effectiveness, no longer meets societal expectations for a comprehensive review of acceptable drug safety.” Stafford-Smith Can J Anaesth 2006;53:973-977

More Related